BridgeMD
New treatment option for Stress Disorders, Post-Traumatic
Official title PT-STRESS Study: Predicting Treatment Success and Dealing With Non-response in the Treatment of PTSD
ClinicalTrials.gov ID: NCT06279598
What this study is testing
- What it's testing
- The aim of this study is to increase understanding of the effectiveness and efficiency of psychological treatment for adult patients with posttraumatic stress disorder -PTSD- and to make it more personalized. Key questions: 1.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adults between the ages of 18 and 65 who were classified with a primary diagnosis of PTSD (based on the DSM-5 criteria).
- Adults who are willing to participate in the study (informed consent)
You likely can't join if
- Insufficient proficiency in the Dutch language.
- Patients who cannot follow the treatment protocol (for example due to prolonged absence) are excluded from the study.
- Patients who use medication that is not stable. If properly set to the last prescribed medication by the doctor there will be advised to continue and...
- Patients that already received an evidence-based form of trauma-oriented treatment for PTSD in the past year and for sufficient treatment duration...
- Patients with serious suicidality that requires acute intervention and structural addition of additional treatment interventions.
- Patients with an intellectual disability.
See the full eligibility criteria
- Adults between the ages of 18 and 65 who were classified with a primary diagnosis of PTSD (based on the DSM-5 criteria).
- Adults who are willing to participate in the study (informed consent)
- Insufficient proficiency in the Dutch language.
- Patients who cannot follow the treatment protocol (for example due to prolonged absence) are excluded from the study.
- Patients who use medication that is not stable. If properly set to the last prescribed medication by the doctor there will be advised to continue and referably not change the medication and its dose during treatment...
- Patients that already received an evidence-based form of trauma-oriented treatment for PTSD in the past year and for sufficient treatment duration, in accordance to the Dutch professional practice guidelines (reference...
- Patients with serious suicidality that requires acute intervention and structural addition of additional treatment interventions.
- Patients with an intellectual disability.
- Patients with a serious addiction as a comorbid problem.
- Patients with an acute mania or a psychotic state.
The study team makes the final eligibility decision.
Where it's taking place
- Deventer, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Deventer, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.